ResearchMoz

Global Dialysis Market Report: 2013 Edition

Koncept Analytics
Published Date » 2013-08-15
No. Of Pages » 55
   
 ESRD (End Stage Renal Disease) refers to permanent kidney failure. It is the final stage of Chronic Kidney Disease (CKD) where the kidney functions at less than 10-15% of the normal capacity. The growing prevalence of diabetes, hypertension and large elderly population are rapidly driving the number of ESRD patients globally. There are two methods used for treating ESRD patients: kidney transplant or dialysis. 
   
 Dialysis is the process of blood purification i.e. the removal of waste and toxic substances from the body and it can be done via two procedures viz. peritoneal dialysis (PD) or hemodialysis (HD). The major dialysis products include dialyzers, hemodialysis machines, dialysis concentrates and peritoneal dialysis products. Diabetes and high blood pressure are among the...
TABLE OF CONTENT

1. Overview
1.1 Chronic Kidney Disease (CKD)
1.2 End Stage Renal Disease (ESRD)
1.2.1 Treatments for ESRD

2. Market Size
2.1 Global Dialysis Market
  • Market Value
  • Dialysis Services Market
  • Dialysis Products Market

2.2 China’s Dialysis Market
  • Market Overview
  • Manufacturers by Region

3. Market Dynamics
3.1 Key Trends and Developments
3.1.1 Distribution of Dialysis Clinics
3.1.2 Dialysis Reimbursement model
3.1.3 New Product Development
3.1.4 Private Equity (PE) Activity in Dialysis Market
3.2 Growth Drivers
3.2.1 Growing Number of Diabetic Patients Worldwide
3.2.2 Global Dialysis Patient Population
3.2.3 Meliorating Global Economy
3.2.4 Increasing Cases of CKD and ESRD
3.2.5 Increasing Expenditure on Healthcare
3.3 Challenges
3.3.1 Risks and After-Effects of Dialysis
3.3.2 Rising Price Pressure in Healthcare Sector
3.3.3 Stringent Regulation
3.3.4 High Treatment Costs

4. Competitive Landscape
4.1 Global Dialysis Market Competition
  • Market Share
  • Market Positioning

4.2 Dialysis Product Contention
  • Hemodialysis Market Share
  • Peritoneal Market Share

4.3 Regional Dialysis Market Contention
4.3.1 China’s Dialysis Market

5. Company Profiles
5.1 DaVita Inc.
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
  • Focus on Company’s Core Values
  • Success through Acquisitions/Partnerships

5.2 Baxter International Inc.
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
  • Product Portfolio Expansion through R&D
  • Strategic Acquisitions & Collaborations

5.3 Fresenius Medical Care
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
  • Sustainable Growth Strategy
  • Focus on Research & Development

6. Market Outlook
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis

List of Tables


Stages of CKD
Renoprotective Strategies for Slowing Progression of CKD
Symptoms & Treatment of Renal Failure
Advantages and Disadvantages of Dialysis Methods
Distribution of Hemodialysis Device Manufacturers by Region in China (2012)
Regional Breakdown of Center Dialysis and Home Dialysis
Change in Share Prices of Dialysis providers' (1/7/2013-2/7/2013)
Dialysis Patients Regional Development (2012)
Risk Factors for CKD
Global Market Position in Major Product Groups (2012)
Number of Patients Treated by Region (2012)
Dependent & Independent Variables (2007–2012)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

List of Figures


GFR across the Stages of CKD
Global Share of ESRD Treatment Procedures (2009-2012)
Global Dialysis Market (2006-2012)
Global Dialysis Market Share by Segments (2012)
Global Dialysis Market Revenue by Segments (2012)
Global Dialysis Product Market (2007-2012)
Global Dialysis Services Market (2007-2012)
Worldwide Breakdown of Center Dialysis & Home Dialysis (2012)
Worldwide Ownership of Dialysis Centers (2012)
Worldwide Regional Dialysis Clinic Operators in 2012
US Dialysis Patients by Payor (2012)
Global Diabetes Population (2006-2012)
Global Diabetes Patients Population by Region (2012)
Dialysis Patient Population Worldwide (2005-2015E)
Dialysis Patient Population Share by Region (2012)
Global GDP (2005-2012)
Global GNI per capita (2007-2012)
Patients with End Stage Renal Disease (2005-2012)
Global Healthcare Expenditure (2007-2011)
Top 5 Dialysis Services Providers Worldwide (2012)
Global Dialysis Products Market Share (2012)
Hemodialysis Products Market Share (2012)
Peritoneal Dialysis Products Market Share (2012)
China’s Dialysis Market by Company (2012)
Hemodialysis Market Share of Domestic and Foreign Manufacturers (2012)
DaVita’s Revenue Share by Business Segments (2012)
DaVita’s Revenue and Net Income Analysis (2009-2012)
Baxter’s Revenue by Business Segments (2012)
Baxter’s Revenues and Net Income (2009-2012)
Fresenius Medical Care’ Revenue Share by Business Segments (2012)
Fresenius Medical Care’ Revenue and Net Income Analysis (2009-2012)
Global Dialysis Market Forecast (2011-2015F)

Upcoming Reports:

Industrial Flue Gas Treatment Systems & Services Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth And Forecast, 2013 - 2019
By - Transparency Market Research
Industrial flue gas treatment system is a set of technologies which is used to remove hazardous gases such as sulphur dioxide (SO2) and nitrogen oxide (NOx) from the emission of industries and power plants. Fossil fuels such as oil and coal contain specified amount of sulphur. When these fuels are combusted in the presence of air almost 95% or more sulphur is directly converted into sulphur dioxide (SO2). When flue gas has excess quantity of oxygen it is again converted into sulphur tri oxide (SO3). In flue gas treatment system the flue gas is generally passed through an ash removal device...
Concentrated Solar Power (CSP) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Concentrated Solar Power (CSP) concentrates a large amount of sunlight by means of mirrors and lenses. This technology is basically utilized to achieve maximum utilization of incident solar power. CSP is one of the most sustainable and promising renewable energies. It improves performance of a solar system as well as provides competitive energy prices. CSP can be categorized according to its product type such as concave, dish stirling and concentrated power tower. All the three products show slight difference in their function from each other. According to technology, CSP is...
Hospital Infection Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018
By - Transparency Market Research
Hospital acquired infections are the infections acquired by the patients following the admission in hospitals within 48 hours. These conditions are also known as nosocomial infections. The causative agents of nosocomial infections include various types of microorganisms such as bacteria (Gram-positive and Gram-negative), viruses and fungi. The most common form of pathogens known to cause infections are superbugs such as staphylococcus aureus, escherichia Coli, enterococcus species, pseudomonas aeruginosa and klebshiella pneumonia, etc. Infections of surgical wounds, urinary tract...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Blackstone Invests $800 Million in Asian Oil-Based Energy Company
Jul 31, 2014  
Blackstone Energy Partners announced to invest $800 million in an Asian based energy company that is led by former industry executives.  Blackstone is popularly considered a part of the world’s largest administrator of alternatives to financial stocks and bonds. New York-based managing director, Angelo Acconcia of Blackstone Energy Partners said in an interview that Tamarind...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...